<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02084706</url>
  </required_header>
  <id_info>
    <org_study_id>2013P002370</org_study_id>
    <nct_id>NCT02084706</nct_id>
  </id_info>
  <brief_title>Needle-Free Injection of Lidocaine for Local Anesthesia Prior to Trigger Digit Injection</brief_title>
  <acronym>J-tip</acronym>
  <official_title>Needle-Free Injection of Lidocaine for Local Anesthesia Prior to Trigger Digit Injection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brigham and Women's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Brigham and Women's Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Jet-injection (J-tip) is a rapid, minimally invasive delivery system that can be used for the
      subdermal injection of lidocaine solution for anesthetic purposes. The device has been found
      effective in pain reduction during IV catheterization in adults and children and lumbar
      puncture in children when compared to placebo saline-jet injection. [1-4].

      We believe that administering local anesthetic via J-tip prior to triamcinolone(40 mg/ml)
      injection could mitigate pain that occurs during and immediately following injection while
      preserving the post-injection pain relief of anesthetic injection. Furthermore, pre-placement
      of the jet-injected local anesthetic may obviate the need for the inclusion of local
      anesthetic into the triamcinolone injection. This would decrease the amount of fluid
      injected, which could have positive pain modulation by decreased tissue disruption.

      Objective: To evaluate the effectiveness of needle free jet injection (J-tip) administration
      of 2% lidocaine in reduction of the pain experienced during trigger digit 40 mg/ml
      triamcinolone injection.

      Hypothesis: Needle free jet injection (J-tip) administration of 2% lidocaine will prove an
      equal or superior means of pain reduction when compared to 2% lidocaine injection in the
      setting of trigger digit triamcinolone injections.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Difference in Visual-analog Score (VAS) for Anticipated Pain Prior to Injection and Actual Pain After Injection</measure>
    <time_frame>Our outcome measure was collected within the 60 seconds before and following the steroid injection.</time_frame>
    <description>Members of both study groups completed the Visual Analog Scale (VAS) pain assessment both prior for anticipated pain and after injection for actual pain; these recorded scores were the primary study endpoint and were later compared to determine the difference in anticipated pain versus actual pain experienced. The VAS ranges from 0-10, where 0 is no pain and 10 is worst possible pain. The outcome measure is the mean anticipated pain minus the actual pain experienced.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Trigger Finger</condition>
  <arm_group>
    <arm_group_label>Triamcinolone (20 g) and 2% Lidocaine injection over A1 pulley</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group one subjects will receive an injection of 0.5mL (20 g) of Triamcinolone and 0.5 mL of 2% Lidocaine over the A1 pulley.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>J-tip lidocaine administration, then steroid injection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group two subjects will receive a needle free &quot;J-tip&quot; administration of 0.5mL of 2% lidocaine prior (2-10 minutes) to needle injection of 0.5mL of Triamcinolone (20 g) over the A1 pulley.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Triamcinolone (20 g) and 2% Lidocaine injection over the A1 pulley</intervention_name>
    <arm_group_label>Triamcinolone (20 g) and 2% Lidocaine injection over A1 pulley</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>2% Lidocaine</intervention_name>
    <arm_group_label>Triamcinolone (20 g) and 2% Lidocaine injection over A1 pulley</arm_group_label>
    <arm_group_label>J-tip lidocaine administration, then steroid injection</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Triamcinolone (20 g)</intervention_name>
    <arm_group_label>Triamcinolone (20 g) and 2% Lidocaine injection over A1 pulley</arm_group_label>
    <arm_group_label>J-tip lidocaine administration, then steroid injection</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>J-tip lidocaine administration</intervention_name>
    <arm_group_label>J-tip lidocaine administration, then steroid injection</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Triamcinolone (20 g) Injection over the A1 pulley.</intervention_name>
    <arm_group_label>J-tip lidocaine administration, then steroid injection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who present to the Hand Clinic at Brigham and Women's Hospital or Brigham and
             Women's Faulkner Hospital, are 18 years of age or older and are indicated for a
             trigger digit steroid injection will be eligible for participation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philip E Blazar, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Brigham and Women's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Lysakowski C, Dumont L, Tram√®r MR, Tassonyi E. A needle-free jet-injection system with lidocaine for peripheral intravenous cannula insertion: a randomized controlled trial with cost-effectiveness analysis. Anesth Analg. 2003 Jan;96(1):215-9, table of contents.</citation>
    <PMID>12505955</PMID>
  </reference>
  <reference>
    <citation>Ferayorni A, Yniguez R, Bryson M, Bulloch B. Needle-free jet injection of lidocaine for local anesthesia during lumbar puncture: a randomized controlled trial. Pediatr Emerg Care. 2012 Jul;28(7):687-90. doi: 10.1097/PEC.0b013e31825d210b.</citation>
    <PMID>22743744</PMID>
  </reference>
  <reference>
    <citation>Jimenez N, Bradford H, Seidel KD, Sousa M, Lynn AM. A comparison of a needle-free injection system for local anesthesia versus EMLA for intravenous catheter insertion in the pediatric patient. Anesth Analg. 2006 Feb;102(2):411-4.</citation>
    <PMID>16428534</PMID>
  </reference>
  <reference>
    <citation>Spanos S, Booth R, Koenig H, Sikes K, Gracely E, Kim IK. Jet Injection of 1% buffered lidocaine versus topical ELA-Max for anesthesia before peripheral intravenous catheterization in children: a randomized controlled trial. Pediatr Emerg Care. 2008 Aug;24(8):511-5. doi: 10.1097/PEC.0b013e31816a8d5b.</citation>
    <PMID>18645542</PMID>
  </reference>
  <reference>
    <citation>Kolind-Sorensen V. Treatment of trigger fingers. Acta Orthop Scand. 1970;41(4):428-32.</citation>
    <PMID>5537268</PMID>
  </reference>
  <reference>
    <citation>Lapidus PW, Guidotti FP. Stenosing tenovaginitis of the wrist and fingers. Clin Orthop Relat Res. 1972 Mar-Apr;83:87-90.</citation>
    <PMID>5014835</PMID>
  </reference>
  <reference>
    <citation>Rhoades CE, Gelberman RH, Manjarris JF. Stenosing tenosynovitis of the fingers and thumb. Results of a prospective trial of steroid injection and splinting. Clin Orthop Relat Res. 1984 Nov;(190):236-8.</citation>
    <PMID>6488636</PMID>
  </reference>
  <reference>
    <citation>Murphy D, Failla JM, Koniuch MP. Steroid versus placebo injection for trigger finger. J Hand Surg Am. 1995 Jul;20(4):628-31. Erratum in: J Hand Surg [Am] 1995 Nov;20(6):1075.</citation>
    <PMID>7594291</PMID>
  </reference>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 5, 2014</study_first_submitted>
  <study_first_submitted_qc>March 10, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 12, 2014</study_first_posted>
  <results_first_submitted>July 20, 2016</results_first_submitted>
  <results_first_submitted_qc>September 7, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 28, 2016</results_first_posted>
  <last_update_submitted>October 27, 2016</last_update_submitted>
  <last_update_submitted_qc>October 27, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 12, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Brigham and Women's Hospital</investigator_affiliation>
    <investigator_full_name>Philip Blazar, MD</investigator_full_name>
    <investigator_title>Associate Professor, Harvard Medical School</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Trigger Finger Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Triamcinolone hexacetonide</mesh_term>
    <mesh_term>Triamcinolone</mesh_term>
    <mesh_term>Triamcinolone Acetonide</mesh_term>
    <mesh_term>Triamcinolone diacetate</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Triamcinolone (20 g) and 2% Lidocaine Injection Over A1 Pulley</title>
          <description>Group one subjects will receive an injection of 0.5mL (20 g) of Triamcinolone and 0.5 mL of 2% Lidocaine over the A1 pulley.
Triamcinolone (20 g) and 2% Lidocaine injection over the A1 pulley
2% Lidocaine
Triamcinolone (20 g)</description>
        </group>
        <group group_id="P2">
          <title>J-tip Lidocaine Administration, Then Steroid Injection</title>
          <description>Group two subjects will receive a needle free &quot;J-tip&quot; administration of 0.5mL of 2% lidocaine prior (2-10 minutes) to needle injection of 0.5mL of Triamcinolone (20 g) over the A1 pulley.
2% Lidocaine
Triamcinolone (20 g)
J-tip lidocaine administration
Triamcinolone (20 g) Injection over the A1 pulley.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="29"/>
                <participants group_id="P2" count="31"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="29"/>
                <participants group_id="P2" count="31"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Triamcinolone (20 g) and 2% Lidocaine Injection Over A1 Pulley</title>
          <description>Group one subjects will receive an injection of 0.5mL (20 g) of Triamcinolone and 0.5 mL of 2% Lidocaine over the A1 pulley.
Triamcinolone (20 g) and 2% Lidocaine injection over the A1 pulley
2% Lidocaine
Triamcinolone (20 g)</description>
        </group>
        <group group_id="B2">
          <title>J-tip Lidocaine Administration, Then Steroid Injection</title>
          <description>Group two subjects will receive a needle free &quot;J-tip&quot; administration of 0.5mL of 2% lidocaine prior (2-10 minutes) to needle injection of 0.5mL of Triamcinolone (20 g) over the A1 pulley.
2% Lidocaine
Triamcinolone (20 g)
J-tip lidocaine administration
Triamcinolone (20 g) Injection over the A1 pulley.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="29"/>
            <count group_id="B2" value="31"/>
            <count group_id="B3" value="60"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66.3" spread="11.2"/>
                    <measurement group_id="B2" value="65.4" spread="10.3"/>
                    <measurement group_id="B3" value="65.8" spread="10.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="34"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                    <measurement group_id="B2" value="31"/>
                    <measurement group_id="B3" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Difference in Visual-analog Score (VAS) for Anticipated Pain Prior to Injection and Actual Pain After Injection</title>
        <description>Members of both study groups completed the Visual Analog Scale (VAS) pain assessment both prior for anticipated pain and after injection for actual pain; these recorded scores were the primary study endpoint and were later compared to determine the difference in anticipated pain versus actual pain experienced. The VAS ranges from 0-10, where 0 is no pain and 10 is worst possible pain. The outcome measure is the mean anticipated pain minus the actual pain experienced.</description>
        <time_frame>Our outcome measure was collected within the 60 seconds before and following the steroid injection.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Triamcinolone (20 g) and 2% Lidocaine Injection Over A1 Pulley</title>
            <description>Group one subjects received an injection of 0.5mL (20 g) of Triamcinolone and 0.5 mL of 2% Lidocaine over the A1 pulley.
Triamcinolone (20 g) and 2% Lidocaine injection over the A1 pulley
2% Lidocaine
Triamcinolone (20 g)</description>
          </group>
          <group group_id="O2">
            <title>J-tip Lidocaine Administration, Then Steroid Injection</title>
            <description>Group two subjects received a needle free &quot;J-tip&quot; administration of 0.5mL of 2% lidocaine prior (2-10 minutes) to needle injection of 0.5mL of Triamcinolone (20 g) over the A1 pulley.
2% Lidocaine
Triamcinolone (20 g)
J-tip lidocaine administration
Triamcinolone (20 g) Injection over the A1 pulley.</description>
          </group>
        </group_list>
        <measure>
          <title>Difference in Visual-analog Score (VAS) for Anticipated Pain Prior to Injection and Actual Pain After Injection</title>
          <description>Members of both study groups completed the Visual Analog Scale (VAS) pain assessment both prior for anticipated pain and after injection for actual pain; these recorded scores were the primary study endpoint and were later compared to determine the difference in anticipated pain versus actual pain experienced. The VAS ranges from 0-10, where 0 is no pain and 10 is worst possible pain. The outcome measure is the mean anticipated pain minus the actual pain experienced.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.6" spread="0.44"/>
                    <measurement group_id="O2" value="2.8" spread="0.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Triamcinolone (20 g) and 2% Lidocaine Injection Over A1 Pulley</title>
          <description>Group one subjects received an injection of 0.5mL (20 g) of Triamcinolone and 0.5 mL of 2% Lidocaine over the A1 pulley.
Triamcinolone (20 g) and 2% Lidocaine injection over the A1 pulley
2% Lidocaine
Triamcinolone (20 g)</description>
        </group>
        <group group_id="E2">
          <title>J-tip Lidocaine Administration, Then Steroid Injection</title>
          <description>Group two subjects received a needle free &quot;J-tip&quot; administration of 0.5mL of 2% lidocaine prior (2-10 minutes) to needle injection of 0.5mL of Triamcinolone (20 g) over the A1 pulley.
2% Lidocaine
Triamcinolone (20 g)
J-tip lidocaine administration
Triamcinolone (20 g) Injection over the A1 pulley.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="29"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="31"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="29"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="31"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Philip Blazar</name_or_title>
      <organization>Brigham and Women's Hospital</organization>
      <phone>617-732-5384</phone>
      <email>pblazar@partners.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

